REFERENCES
1. Cahill N, Sonneveldt E, Stover J,
Weinberger M, Williamson J, Wei C, et al. Modern contraceptive use,
unmet need, and demand satisfied among women of reproductive age who are
married or in a union in the focus countries of the Family Planning 2020
initiative: a systematic analysis using the Family Planning Estimation
Tool. Lancet. 2018;391(10123):870-82.
2. Committee Opinion No. 670:
Immediate Postpartum Long-Acting Reversible Contraception. Obstet
Gynecol. 2016;128(2) e32-e7.
3. Birgisson NE, Zhao Q, Secura GM,
Madden T, Peipert JF. Preventing Unintended Pregnancy: The Contraceptive
CHOICE Project in Review. Journal of Women’s Health. 2105;24(5):349-53.
4. Morse J, Freedman L, Speidel JJ,
Thompson KM, Stratton L, Harper CC. Postabortion contraception:
qualitative interviews on counseling and provision of long-acting
reversible contraceptive methods. Perspect Sex Reprod Health.
2012;44(2):100-6.
5. Masilela S. Improvement in abortion
and contraception led by data-driven decisions in gauteng province,
South Africa. International Journal of Gynecology and Obstetrics.
2015;2015(131):e65.
6. Harper C, Thompson K, Waxman NJ,
Speidel J. Provision of long-acting reversible contraception at US
abortion facilities and barriers to immediate postabortion insertion.
Contraception. 2009;80(2):197-8.
7. Chersich MF, Wabiri N, Risher K,
Shisana O, Celentano D, Rehle T, et al. Contraception coverage and
methods used among women in South Africa: a national household survey. S
Afr Med J. 2017;107(4):307-14.
8. Baldwin MK, Edelman AB. The effect
of long-acting reversible contraception on rapid repeat pregnancy in
adolescents: a review. J Adolesc Health. 2013;52(4 Suppl):S47-53.
9. Korjamo R, Mentula M, Heikinheimo
O. Immediate versus delayed initiation of the levonorgestrel-releasing
intrauterine system following medical termination of pregnancy - 1 year
continuation rates: a randomised controlled trial. BJOG : an
international journal of obstetrics and gynaecology.
2017;124(13):1957-64.
10. Hohmann HL, Reeves MF, Chen BA,
Perriera LK, Hayes JL, Creinin MD. Immediate versus delayed insertion of
the levonorgestrel-releasing intrauterine device following dilation and
evacuation: a randomized controlled trial. Contraception.
2012;85(3):240-5.
11. Okusanya BO, Oduwole O, Effa EE.
Immediate postabortal insertion of intrauterine devices. Cochrane
Database Syst Rev. 2014(7):CD001777.
12. Cooper M, Cameron ST. Successful
implementation of immediate postpartum intrauterine contraception
services in Edinburgh and framework for wider dissemination. Int J
Gynaecol Obstet. 2018;143:56-61.
13. Jatlaoui TC, Whiteman MK, Jeng G,
Tepper NK, Berry-Bibee E, Jamieson DJ, et al. Intrauterine Device
Expulsion After Postpartum Placement: A Systematic Review and
Meta-analysis. Obstetrics & Gynecology. 2018;132(4):895-905.
14. Lopez LM, Bernholc A, Hubacher D,
Stuart G, Van Vliet HA. Immediate postpartum insertion of intrauterine
device for contraception. Cochrane Database Syst Rev. 2015;6(CD003036).
15. Korjamo R, Mentula M, Heikinheimo
O. Expulsions and adverse events following immediate and later insertion
of a levonorgestrel-releasing intrauterine system after medical
termination of late first- and second-trimester pregnancy: a randomised
controlled trial. BJOG : an international journal of obstetrics and
gynaecology. 2017;124(13):1965-72.
16. Korjamo R, Mentula M, Heikinheimo
O. Fast-track vs. delayed insertion of the levonorgestrel-releasing
intrauterine system after early medical abortion - a randomized trial.
Contraception. 2017;96(5):344-51.
17. Cremer M, Bullard KA, Mosley RM,
Weiselberg C, Molaei M, Lerner V, et al. Immediate vs. delayed
post-abortal copper T 380A IUD insertion in cases over 12 weeks of
gestation. Contraception. 2011;83(6):522-7.
18. Bednarek PH, Creinin MD, Reeves
MF, Cwiak C, Espey E, Jensen JT, et al. Immediate versus delayed IUD
insertion after uterine aspiration. N Engl J Med. 2011;364(23):2208-17.
19. Hognert H, Kopp Kallner H,
Cameron S, Nyrelli C, Jawad I, Heller R, et al. Immediate versus delayed
insertion of an etonogestrel releasing implant at medical abortion—a
randomized controlled equivalence trial. Human reproduction (Oxford).
2016;31(11):2484-90.
20. Appareddy S, Pryor J, Bailey B.
Inter-pregnancy interval and adverse outcomes: Evidence for an
additional risk in health disparate populations. J Matern Fetal Neonatal
Med. 2017;30(21):2640-4.